Cargando…

Overexpression of urokinase-type plasminogen activator in pterygia and pterygium fibroblasts

PURPOSE: Urokinase-type plasminogen activator (uPA) is a protease involved in tissue remodeling and cell migration. Little is known about the expression of uPA in pterygium. The purpose of this study was to investigate the expression of uPA mRNA and activities in various stages of surgically excised...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chao, Shih-Chun, Hu, Dan-Ning, Yang, Pei-Yu, Lin, Ching-Yang, Yang, Shun-Fa
Formato:	Texto
Lenguaje:	English
Publicado:	Molecular Vision 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3017801/ https://www.ncbi.nlm.nih.gov/pubmed/21224999

Ejemplares similares

Plasma Soluble Urokinase-Type Plasminogen Activator Receptor Level as a Predictor of the Severity of Community-Acquired Pneumonia
por: Tsai, Ping-Kun, et al.
Publicado: (2019)

Pterygium surgery by double-sliding flaps procedure: Comparison between primary and recurrent pterygia
por: Lee, Jong Soo, et al.
Publicado: (2021)

Terminalia catappa attenuates urokinase-type plasminogen activator expression through Erk pathways in Hepatocellular carcinoma
por: Yeh, Chao-Bin, et al.
Publicado: (2014)

Optimal size of pterygium excision for limbal conjunctival autograft using fibrin glue in primary pterygia
por: Hwang, Ho Sik, et al.
Publicado: (2018)

Serum Fibroblast Growth Factor 21 in Patients with and without Pterygia
por: Yaghoobi, Gholamhosein, et al.
Publicado: (2020)

Urokinase-type plasminogen activator: proenzyme, receptor, and inhibitors
Publicado: (1987)

Distribution of urokinase-type plasminogen activator immunoreactivity in the mouse
Publicado: (1984)

Localization of Urokinase‐type Plasminogen Activator, Plasminogen Activator Inhibitor‐1, 2 and Plasminogen in Colon Cancer
por: Naitoh, Hiroyuki, et al.
Publicado: (1995)

The plasminogen system and cell surfaces: evidence for plasminogen and urokinase receptors on the same cell type
Publicado: (1986)

Urokinase-type plasminogen activator: a new target for male contraception?
por: Qin, Ying, et al.
Publicado: (2015)

Linkage of extracellular plasminogen activator to the fibroblast cytoskeleton: colocalization of cell surface urokinase with vinculin
Publicado: (1988)

Uncharged isocoumarin-based inhibitors of urokinase-type plasminogen activator
por: Heynekamp, Justin J, et al.
Publicado: (2006)

Urokinase-type plasminogen activator receptor in IgA nephropathy
por: Ahn, Shin-Young, et al.
Publicado: (2014)

Urokinase-type Plasminogen Activator Induces Neurorepair in the Ischemic Brain
por: Merino, Paola, et al.
Publicado: (2018)

Licochalcone A Suppresses Migration and Invasion of Human Hepatocellular Carcinoma Cells through Downregulation of MKK4/JNK via NF-κB Mediated Urokinase Plasminogen Activator Expression
por: Tsai, Jen-Pi, et al.
Publicado: (2014)

Immunohistochemical localization of urokinase-type plasminogen activator, urokinase-type plasminogen activator receptor and α2-antiplasmin in human corneal perforation: a case report
por: Sugioka, Koji, et al.
Publicado: (2012)

The Treatment of Pterygia with the Galvano-Cautery
por: Hobbs, Arthur G.
Publicado: (1894)

Urokinase, urokinase receptor, and plasminogen activator inhibitor-1 expression on podocytes in immunoglobulin A glomerulonephritis
por: Lee, Ji-Hye, et al.
Publicado: (2014)

Shear stress modulates macrophage-induced urokinase plasminogen activator expression in human chondrocytes
por: Yeh, Chih-Chang, et al.
Publicado: (2013)

Overexpression of Urokinase‐type Plasminogen Activator in Human Gastric Cancer Cell Line (AGS) Induces Tumorigenicity in Severe Combined Immunodeficient Mice
por: Choi, Yang‐Kyu, et al.
Publicado: (2002)

In silico docking of urokinase plasminogen activator and integrins
por: Degryse, Bernard, et al.
Publicado: (2008)

Evaluation of Urokinase Plasminogen Activator Receptor, Soluble Urokinase Plasminogen Activator Receptor, and β1 Integrin in Patients with Hodgkin's Lymphoma
por: Kouhpayeh, Shirin, et al.
Publicado: (2017)

Distinct localizations of urokinase-type plasminogen activator and its type 1 inhibitor under cultured human fibroblasts and sarcoma cells
Publicado: (1987)

Prognostic significance of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in primary breast cancer.
por: Knoop, A., et al.
Publicado: (1998)

Urokinase-type plasminogen activator is induced in migrating capillary endothelial cells
Publicado: (1987)

immunocytochemical localization of urokinase-type plasminogen activator in lewis lung carcinoma
por: Skriver, L, et al.
Publicado: (1984)

Urokinase-Type Plasminogen Activator Deficiency Promotes Neoplasmatogenesis in the Colon of Mice()()()
por: Karamanavi, Elisavet, et al.
Publicado: (2014)

Urokinase-type plasminogen activator promotes synaptic repair in the ischemic brain
por: Diaz, Ariel, et al.
Publicado: (2018)

Urokinase-type Plasminogen Activator Promotes Synaptic Recovery in the Ischemic Brain
por: Yepes, Manuel
Publicado: (2018)

Discovery of a novel conformational equilibrium in urokinase-type plasminogen activator
por: Kromann-Hansen, Tobias, et al.
Publicado: (2017)

Urokinase-type plasminogen activator blockade ameliorates experimental colitis in mice
por: Kida, Yoshifumi, et al.
Publicado: (2023)

Exogenous Urokinase Inhibits Proteasomal Degradation of Its Cognate Urokinase Plasminogen Activator Receptor
por: Zhu, Ran, et al.
Publicado: (2022)

An uncommon case of upper limb pterygia
por: Deodhar, Avinash
Publicado: (2012)

Urokinase-type plasminogen activator receptor as a predictor of poor outcome in patients with systemic inflammatory response syndrome
por: Wu, Xiao-ling, et al.
Publicado: (2013)

Overexpression of forkhead box M1 and urokinase-type plasminogen activator in gastric cancer is associated with cancer progression and poor prognosis
por: Ma, Jie, et al.
Publicado: (2017)

Plasminogen Activator Inhibitor-1 Protects Mice Against Cardiac Fibrosis by Inhibiting Urokinase-type Plasminogen Activator-mediated Plasminogen Activation
por: Gupta, Kamlesh K., et al.
Publicado: (2017)

Reduced Expression of Urokinase Plasminogen Activator in Brown Adipose Tissue of Obese Mouse Models
por: Wu, Chung-Ze, et al.
Publicado: (2021)

Deficiency of Urokinase Plasminogen Activator May Impair β Cells Regeneration and Insulin Secretion in Type 2 Diabetes Mellitus
por: Wu, Chung-Ze, et al.
Publicado: (2019)

Aggregation and retention of human urokinase type plasminogen activator in the yeast endoplasmic reticulum
por: Agaphonov, Michael O, et al.
Publicado: (2002)

Inhibition of urokinase-type plasminogen activator expression by dihydroartemisinin in breast cancer cells
por: ZHANG, SHUQUN, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_fob7o709n89g2d9i10crvuc0m6